Tipula Iridescent Virus
I recently reported in this journal some observations on the structure of Sericesthis iridescent virus (SIV) (Wrigley, ~969) . In this short communication I report similar observations on the closely related Tipula iridescent virus (TIV) and interpret them in the same way.
The T1V used in this study was obtained from Dr S. Tojo, Tokyo University. It was treated in aqueous suspension in the same way as SIV by mixing at room temperature with an equal volume of the nasal decongestant 'Afrin' (' Drixine', Schering Corp., New Jersey, U.S.A.) . The result of this treatment was the same as for SIV; protein subunits (i.e. morphological units or capsomeres) on the particle surface were revealed by negative stain (4 % (w/v) potassium phosphotungstate, pH 7) in the electron microscope. About I o % of the particles reacted in this way, but after only 24 hr, compared to 48 hr for SIV. Figure I a, b shows two such particles, and although individual subunits are not resolved the rows in which they lie can be clearly seen in parts of the particles. Figure I e shows the same particle as (a) but with a possible interpretation of the icosahedron edges superimposed. Vertex A ( Fig. I c) was located, without reference to the particle edges, as a point where five of the more prominent rows of subunits seem to converge. Vertex B was easily located, being on the outer profile of the particle, and there are five rows of subunits crossing the line joining it to A (including the rows which actually pass through A and B). This is what would be expected if the particle had the same structure as the model proposed for SIV ( Fig. I d) . Furthermore ~4 or 15 rows of subunits may be counted crossing the line E to B; the SIV model has r5. Vertex C was located approximately by assuming that it should lie on the fifth row of subunits to the left of A. It was more difficult to locate vertex D, which was positioned by reference to the other corners. The S1V model has I I rows of subunits crossing the line A-D in a lower-left to upper-right direction, and the particle in Figure I c of TIV is therefore consistent with the SIV model in a general way. This model has I562 surface subunits altogether, although structures with I472 or I292 subunits were other alternatives for SIV. The I472 subunit structure is supported by evidence from TIV left for about z months in water at 4 °. As with SIV many triangular arrays of subunits were found after this storage, presumably from particles which had collapsed on the electron microscope grid. Individual subunits were not resolved on these TIV triangles, but using the triangle edge-length 7I I + I8 ~ (66 measurements) and the centre-to-centre distance l = 71.5 ~ between subunits, it may be inferred that there were ten subunits per triangle edge (55 hexagonally packed subunits per triangle, i.e. t = 55 'trisymmetrons'; see Wrigley, I969) .
Unlike the SIV triangles, many TIV triangles were seen to be arranged in groups of five as shown in Fig. 2 (left) and sketched in Fig. 2 (right) . The amount of'overlap' between one triangle and another was investigated to see whether it showed any regularity. The ratio between 'overlap' a and triangle edge-length b (sketch, Fig. 2 right) was determined; 58 independent values of a/b were obtained and their distribution is shown in the histogram, Fig. 2 (Wrigley, I969) this is the structure corresponding to point (7, 7) (not to point (I I, 2) which corresponds to a different 1472-subunit arrangement). In addition to the t = 55 trisymmetrons (the triangles) this structure also has p = 3I pentasymmetrons (pentagonal fragments) and no disymmetrons (linear fragments; d = o). No pentasymmetrons were found in the degraded TIV preparation, but the evidence from grouped triangles in favour of the I472-subunit structure seems stronger than the evidence for the I562-subunit structure from 'Afrin'-treated TIV.
There are so many points of similarity between SIV and TIV--sedimentation coefficient, DNA content and base ratio, and general appearance in the electron microscope--that although they are definitely serologically distinct, their protein coat structures are very likely to be identical. The edge-length L of the intact icosahedral (Williams & Smith, 1958 ) particles of TIV measured in the same way as for S1V was 824 _+ 27 A compared to 860 + 27 ~ for SIV; the uncertainty of 3"3 % is the standard deviation of 74 independent measurements. The centre-to-centre distance l between protein subunits on the TIV surface was 71"5 + 6.1 ~ compared to 7o.I + 2-3 ~ for SIV. The 6-1 ~ standard deviation for TIV is greater than for SIV because I is based on the distance between rows of subunits on intact particles with no correction for foreshortening; for SIV l was measured direct on the triangles which required no such correction. However, the ratio L/1 is 11-5 + I"4 for TIV compared to I2"2 5 + 0-8 for SIV, and defines an 'experimental region' on the Goldberg diagram (see SIV paper) similar to that for SIV.
In summary, if only SIV is considered, it most probably has I562 subunits in the outer protein coat, though I472 and i292 cannot be excluded (Wrigley, 1969) . If only TIV is considered, it most probably has I472 subunits. However, the I562-subunit structure cannot be excluded for TIV (evidence from 'Afrin'-treated particles), nor can the IZ92-subunit structure: it lies closer to the experimental value L/l --11.5 than does 1472, but its d = o configuration would give triangle 'overlap' a/b = o'235 (see histogram, Fig. 2 ). If one assumes that both SIV and TIV have the same structure then the joint favourite is probably I472. All these values are much greater than the TIV structure with 812 morphological subunits suggested by Smith & Hills (196o) . An electron micrograph of disrupted TIV by Almeida, Waterson & Plowright (1967) also seems to me to show far more than 812 subunits.
Chilo iridescent virus has been subjected to similar experiments and its edge-length L found to be 850+30 ~,. However it has so far failed to respond to the 'Afrin' treatment so that I have no information on its subunits. The effect of'Afrin' itself is still not understood. I have tested the components of 'Afrin' separately (kindly supplied by Schering Corporation, U.S.A., and its Australian subsidiary) on each of the three viruses. Repeated trials with the individual components had no effect; the action of whole ' Afrin' must be due to all or some of the components acting together. 
